30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

CHARLES WU

Insider profile

CHARLES WU's trades of Gyre Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-04-09 2024-04-09 PrS Proposed sale
56,109
269.63
US$3,048,789
56,109 269.63 US$3,048,789
2024-04-08 2024-04-08 PrS Proposed sale
35,083
35.04
US$4,929,087
35,083 35.04 US$4,929,087
2024-04-05 2024-04-05 PrS Proposed sale
74,153
339.78
US$2,410,171
74,153 339.78 US$2,410,171
2024-04-04 2024-04-04 PrS Proposed sale
777
17.29
US$13,433
777 17.29 US$13,433
2024-04-03 2024-04-03 PrS Proposed sale
729
17.00
US$12,393
729 17.00 US$12,393
2024-04-02 2024-04-02 PrS Proposed sale
3,271
16.69
US$54,607
3,271 16.69 US$54,607